This website uses cookies for improving and personalising our services and marketing.

Full information can be seen on our Privacy Policy.

Accept Cookies
Like Us!
Watch Us!
Follow Us!
Contact Us!

Providing enabling technologies to support you from Discovery to Delivery.

Esco Pharma News

News Esco at the ASHP in Baltimore!

Esco at the ASHP in Baltimore!


Esco at the ASHP in Baltimore!

Esco participated in the recently concluded prestigious conference, the American Society of Health-System Pharmacists (ASHP) Summer Meetings and Exhibitions 2016, held on June 11-15 at the Baltimore Convention Center, Baltimore, Maryland, USA.


Mr. Ryan Clayton, Ms. Zharmaine Solivet, and Mr. XL Lin during the ASHP Summer Meetings


ASHP is a national professional organization whose more than 43,000 members include pharmacists, student pharmacists, and pharmacy technicians who serve as patient care providers on healthcare teams in acute and ambulatory settings. (ASHP, 2016)

Lectures were presented under the 4 main categories:

  1. Medication Safety Collaborative
  2. Informatics Institute
  3. Pharmacy, Practice and Policy
  4. Ambulatory Care Conference

Handling Hazardous Drugs in Healthcare Settings

A special topic on hazardous drugs was discussed. Patricia Kienle, the author of USP<800> Hazardous Drugs – Handling in Healthcare Settings, talked about the components of minimizing exposure to hazardous drugs during handling – 1. Facilities and 2. Other elements.

Facilities include the following:

  1. Primary Engineering Controls (PEC)

Primary engineering controls such as Containment Ventilated Enclosures (CVE), Containment Aseptic Containment Isolators (CACI), and Biological Safety Cabinets (BSC) are highlighted as the main sources of operator protection during hazardous drug handling.

  1. Secondary Engineering Controls (SEC)

The room where the primary engineering control is placed should follow the minimum requirements such as fixed walls that separates the room from non-hazardous drug compounding area, negatively pressurized, and should have appropriate number of air changes per hour (ACPH).

  1. Supplemental Engineering Controls e.g. closed-system transfer devices (CSTDs)

Other elements include the following:

  1. Personnel training and monitoring
  2. Medical surveillance
  3. Environmental monitoring
  4. Personal protective equipment
  5. Decontamination and cleaning
  6. Spill management

Esco’s solution to USP <797>/<800> Pharmacy Compounding Challenges

In relation to PECs, Esco has showcased its line of pharmacy compounding solutions during the exhibition.

Esco’s pharmacy compounding isolators are compliant to international standards such as USP <797>/<800>, FDA cGMP, PIC/S, NIOSH, OSHA, and CETA. These isolators are designed to fit your applications.


Positive Pressure Models

Suitable for compounding non-hazardous drugs such as:

  • Total Parenteral Nutrition
  • Ophthalmic preparations
  • Central IV Admixtures
Negative Pressure Models

Suitable for compounding hazardous drugs such as:

  • Antineoplastic agents
  • Hormones
  • Antibody drug conjugates


In Esco, we consider the type of facility you are working at. If you have plans in upgrading your facilities, here are our recommendations for isolators:

503 (a) facilities 503 (b) facilities

Streamline® Compounding Isolators

Isoclean® Healthcare Platform Isolators

Isoclean® Healthcare Platform Isolators

Containment Barrier Isolator

General Processing Platform Isolator



See you also at:

What? Where? When?
2016 Fall Hospital Pharmacy Conference Hyatt Regency O’Hare, Chicago, Illinois October 17 – 19, 2016
2016 ASHP Midyear Clinical Meeting and Exhibition Las Vegas, Nevada December 4 – 8, 2016